Clinical trials: sponsored by Institut du Cancer de Montpellier - Val d'Aurelle
Bladder Cancer
Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
- Trial name
- GEMCIRAV (NCT00556621)
- Testing
- cisplatin, gemcitabine hydrochloride, biopsy
- Where
- France
- Volunteers
- 14 people
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
Unspecified Adult Solid Tumor, Protocol Specific
Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
RATIONALE: Drugs used in chemotherapy, such as capecitabine, irinotecan, and oxaliplatin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.
- Trial name
- NCT00544063
- Testing
- irinotecan hydrochloride, oxaliplatin
- Where
- France
- Volunteers
- 33 people
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle